The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the UK Health Security Agency (formerly Public Health England) to provide preclinical services in support of the development of medical countermeasures against chemical, biological, radiological, and nuclear threats. The contract includes task areas for small animal models, non-human primate models, animal replacement and non-traditional animal models,...
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Ministry of Defence (doing business as D S T L), a U.K. government entity, to provide pre-clinical models of infectious diseases. The $40 million multiple-award contract runs from July 2017 to July 2024 and is part of NIAID's Preclinical Models of Infectious Diseases program. Under this contract, the Ministry of Defence will conduct research and...
The federal contract IDV award, valued at up to $146.3 million over a 7-year ordering period, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the Ministry of Defence (D S T L) of the United Kingdom. The contract aims to provide a broad range of animal and animal replacement models to evaluate the efficacy of candidate countermeasures, including vaccines, therapeutics, and diagnostics, against infectious agents under NIAID's purview. This includes models for RNA...
This is a single-award Indefinite Delivery Contract (IDC) awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to the UK Health Security Agency (formerly Public Health England). The $2,380,824.61 contract is focused on comparing Ebola virus infection and disease in animal models and humans, as well as assessing animal models for medical countermeasure development. The contract has a period of performance through October 2022 and is not set aside for any...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded an indefinite delivery contract to the UK Health Security Agency to support the Biomedical Advanced Research and Development Authority. The single award IDV has a potential value of $100 million and a period of performance through September 2027. Two task orders have been issued against the contract to date, totaling over $18 million, for biological animal model and medical...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
The Indefinite Delivery Contract (IDC) 75N93024D00028 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Tennessee, a non-profit educational institution. The $146.3M contract has an ordering period ending in July 2031 and covers the development and use of animal and animal replacement models to evaluate candidate countermeasures (e.g., therapeutics, vaccines,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Contract (IDC) worth up to $146,300,000 to The Johns Hopkins University to provide pre-clinical models of infectious diseases. The contract has a period of performance from July 2024 to July 2031. The contract encompasses four task areas: (A) Small Animal Models, (B) Non-Human Primate Models, (C) Animal Replacement and Non-Traditional Animal Models, and (D) Generation and Distribution...
This is a multiple-award Indefinite Delivery Contract (IDC) with a $80,000,000 ceiling value, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to the UK Health Security Agency (formerly Public Health England), a government agency in the United Kingdom. The contract is for the provision of pre-clinical models and services related to infectious disease research and development, including biological animal model development, medical countermeasure development, and contract management support.
Task orders issued to date under this IDC total over $18 million, with the most recent award being a $1,662,002 cost-no-fee delivery order for Task Order B-14. The contract does not utilize any set-aside designations. The period of performance runs through July 2024. This IDC supports NIAID's broader research and development efforts to combat chemical, biological, radiological, and nuclear threats through collaboration with international partners like the UK Health Security Agency.